RBC Capital Maintains Outperform on Autoliv, Lowers Price Target to $146
RBC Capital analyst Tom Narayan maintains Autoliv (NYSE:ALV) with a Outperform and lowers the price target from $147 to $146.
Stocks · News reference
This Autoliv Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Analysts downgraded Accelerant, Autoliv, Compass Therapeutics, Wave Life Sciences and PG&E; price targets for CMPX and PCG were cut.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Autoliv Retires 1,232,671 Repurchased Shares, Reducing Issued Shares To 74,421,702, Of Which 72,006,695 Are Outstanding As Of Sept. 30, 2026
Jefferies Maintains Hold on Autoliv, Lowers Price Target to $119
Jefferies analyst Vanessa Jeffriess maintains Autoliv (NYSE:ALV) with a Hold and lowers the price target from $134 to $119.
This Dow Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Analysts downgraded SoundThinking, Moderna, Accelerant, Mobileye and Dow, revising their ratings and price targets.
Microsoft To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed upgrades, downgrades and reiterations.
TD Cowen Downgrades Accelerant Hldgs to Hold, Lowers Price Target to $20.25